nodes	percent_of_prediction	percent_of_DWPC	metapath
Mycophenolate mofetil—Nephritis—Methimazole—Graves' disease	0.0709	0.0875	CcSEcCtD
Mycophenolate mofetil—Nephritis—Propylthiouracil—Graves' disease	0.0603	0.0744	CcSEcCtD
Mycophenolate mofetil—Interstitial pneumonia—Propylthiouracil—Graves' disease	0.0426	0.0526	CcSEcCtD
Mycophenolate mofetil—Ageusia—Methimazole—Graves' disease	0.0299	0.0369	CcSEcCtD
Mycophenolate mofetil—Interstitial lung disease—Propylthiouracil—Graves' disease	0.0291	0.0359	CcSEcCtD
Mycophenolate mofetil—Skin ulcer—Propylthiouracil—Graves' disease	0.0264	0.0327	CcSEcCtD
Mycophenolate mofetil—Ageusia—Propylthiouracil—Graves' disease	0.0254	0.0314	CcSEcCtD
Mycophenolate mofetil—Liver injury—Propylthiouracil—Graves' disease	0.0245	0.0302	CcSEcCtD
Mycophenolate mofetil—Aplastic anaemia—Methimazole—Graves' disease	0.0227	0.0281	CcSEcCtD
Mycophenolate mofetil—Lymphadenopathy—Methimazole—Graves' disease	0.0206	0.0254	CcSEcCtD
Mycophenolate mofetil—Aplastic anaemia—Propylthiouracil—Graves' disease	0.0193	0.0239	CcSEcCtD
Mycophenolate mofetil—Lymphadenopathy—Propylthiouracil—Graves' disease	0.0175	0.0216	CcSEcCtD
Mycophenolate mofetil—Hepatic failure—Propylthiouracil—Graves' disease	0.0166	0.0205	CcSEcCtD
Mycophenolate mofetil—Renal failure acute—Propylthiouracil—Graves' disease	0.0162	0.02	CcSEcCtD
Mycophenolate mofetil—IMPDH2—eye—Graves' disease	0.0143	0.0753	CbGeAlD
Mycophenolate mofetil—IMPDH1—eye—Graves' disease	0.0142	0.0748	CbGeAlD
Mycophenolate mofetil—Neuropathy peripheral—Methimazole—Graves' disease	0.0133	0.0164	CcSEcCtD
Mycophenolate mofetil—Jaundice—Methimazole—Graves' disease	0.0132	0.0163	CcSEcCtD
Mycophenolate mofetil—CES2—eye—Graves' disease	0.013	0.0684	CbGeAlD
Mycophenolate mofetil—Agranulocytosis—Methimazole—Graves' disease	0.0126	0.0156	CcSEcCtD
Mycophenolate mofetil—Hepatitis—Methimazole—Graves' disease	0.0122	0.015	CcSEcCtD
Mycophenolate mofetil—SLCO1B3—pituitary gland—Graves' disease	0.0118	0.0621	CbGeAlD
Mycophenolate mofetil—Neuropathy peripheral—Propylthiouracil—Graves' disease	0.0113	0.0139	CcSEcCtD
Mycophenolate mofetil—Jaundice—Propylthiouracil—Graves' disease	0.0112	0.0139	CcSEcCtD
Mycophenolate mofetil—Agranulocytosis—Propylthiouracil—Graves' disease	0.0107	0.0133	CcSEcCtD
Mycophenolate mofetil—Alopecia—Methimazole—Graves' disease	0.0107	0.0133	CcSEcCtD
Mycophenolate mofetil—IMPDH2—pituitary gland—Graves' disease	0.0106	0.0559	CbGeAlD
Mycophenolate mofetil—IMPDH2—adipose tissue—Graves' disease	0.0106	0.0557	CbGeAlD
Mycophenolate mofetil—IMPDH1—pituitary gland—Graves' disease	0.0106	0.0555	CbGeAlD
Mycophenolate mofetil—IMPDH1—adipose tissue—Graves' disease	0.0105	0.0553	CbGeAlD
Mycophenolate mofetil—Haemoglobin—Propylthiouracil—Graves' disease	0.0104	0.0128	CcSEcCtD
Mycophenolate mofetil—Haemorrhage—Propylthiouracil—Graves' disease	0.0103	0.0128	CcSEcCtD
Mycophenolate mofetil—Hepatitis—Propylthiouracil—Graves' disease	0.0103	0.0128	CcSEcCtD
Mycophenolate mofetil—CES1—connective tissue—Graves' disease	0.0103	0.0543	CbGeAlD
Mycophenolate mofetil—CES2—pituitary gland—Graves' disease	0.00967	0.0508	CbGeAlD
Mycophenolate mofetil—CES2—adipose tissue—Graves' disease	0.00963	0.0506	CbGeAlD
Mycophenolate mofetil—Vertigo—Methimazole—Graves' disease	0.00951	0.0117	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Methimazole—Graves' disease	0.00947	0.0117	CcSEcCtD
Mycophenolate mofetil—IMPDH2—thyroid gland—Graves' disease	0.00917	0.0482	CbGeAlD
Mycophenolate mofetil—Alopecia—Propylthiouracil—Graves' disease	0.00914	0.0113	CcSEcCtD
Mycophenolate mofetil—IMPDH1—thyroid gland—Graves' disease	0.00911	0.0479	CbGeAlD
Mycophenolate mofetil—Myalgia—Methimazole—Graves' disease	0.00901	0.0111	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Methimazole—Graves' disease	0.00901	0.0111	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Propylthiouracil—Graves' disease	0.00881	0.0109	CcSEcCtD
Mycophenolate mofetil—Oedema—Methimazole—Graves' disease	0.00864	0.0107	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Methimazole—Graves' disease	0.00846	0.0104	CcSEcCtD
Mycophenolate mofetil—CES2—thyroid gland—Graves' disease	0.00833	0.0438	CbGeAlD
Mycophenolate mofetil—Vertigo—Propylthiouracil—Graves' disease	0.00809	0.00999	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Propylthiouracil—Graves' disease	0.00806	0.00995	CcSEcCtD
Mycophenolate mofetil—CES1—adipose tissue—Graves' disease	0.00793	0.0417	CbGeAlD
Mycophenolate mofetil—Musculoskeletal discomfort—Methimazole—Graves' disease	0.00787	0.00972	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Methimazole—Graves' disease	0.00776	0.00958	CcSEcCtD
Mycophenolate mofetil—Somnolence—Methimazole—Graves' disease	0.00768	0.00948	CcSEcCtD
Mycophenolate mofetil—Myalgia—Propylthiouracil—Graves' disease	0.00766	0.00946	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Propylthiouracil—Graves' disease	0.00766	0.00946	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Methimazole—Graves' disease	0.0076	0.00939	CcSEcCtD
Mycophenolate mofetil—Oedema—Propylthiouracil—Graves' disease	0.00734	0.00907	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Propylthiouracil—Graves' disease	0.00719	0.00888	CcSEcCtD
Mycophenolate mofetil—Urticaria—Methimazole—Graves' disease	0.00686	0.00847	CcSEcCtD
Mycophenolate mofetil—CES1—thyroid gland—Graves' disease	0.00686	0.0361	CbGeAlD
Mycophenolate mofetil—Body temperature increased—Methimazole—Graves' disease	0.00683	0.00843	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.00669	0.00826	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Propylthiouracil—Graves' disease	0.0066	0.00814	CcSEcCtD
Mycophenolate mofetil—Somnolence—Propylthiouracil—Graves' disease	0.00653	0.00806	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Propylthiouracil—Graves' disease	0.00647	0.00798	CcSEcCtD
Mycophenolate mofetil—Pruritus—Methimazole—Graves' disease	0.00611	0.00755	CcSEcCtD
Mycophenolate mofetil—Urticaria—Propylthiouracil—Graves' disease	0.00583	0.00721	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Propylthiouracil—Graves' disease	0.00581	0.00717	CcSEcCtD
Mycophenolate mofetil—Vomiting—Methimazole—Graves' disease	0.00549	0.00678	CcSEcCtD
Mycophenolate mofetil—Rash—Methimazole—Graves' disease	0.00545	0.00673	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Methimazole—Graves' disease	0.00544	0.00672	CcSEcCtD
Mycophenolate mofetil—Headache—Methimazole—Graves' disease	0.00541	0.00668	CcSEcCtD
Mycophenolate mofetil—Pruritus—Propylthiouracil—Graves' disease	0.0052	0.00642	CcSEcCtD
Mycophenolate mofetil—Nausea—Methimazole—Graves' disease	0.00513	0.00634	CcSEcCtD
Mycophenolate mofetil—Vomiting—Propylthiouracil—Graves' disease	0.00467	0.00577	CcSEcCtD
Mycophenolate mofetil—Rash—Propylthiouracil—Graves' disease	0.00463	0.00572	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Propylthiouracil—Graves' disease	0.00463	0.00571	CcSEcCtD
Mycophenolate mofetil—Headache—Propylthiouracil—Graves' disease	0.0046	0.00568	CcSEcCtD
Mycophenolate mofetil—Nausea—Propylthiouracil—Graves' disease	0.00436	0.00539	CcSEcCtD
Mycophenolate mofetil—CYP2C8—pituitary gland—Graves' disease	0.00389	0.0204	CbGeAlD
Mycophenolate mofetil—ABCG2—pituitary gland—Graves' disease	0.00378	0.0199	CbGeAlD
Mycophenolate mofetil—ABCG2—adipose tissue—Graves' disease	0.00377	0.0198	CbGeAlD
Mycophenolate mofetil—CYP3A5—adipose tissue—Graves' disease	0.0035	0.0184	CbGeAlD
Mycophenolate mofetil—ABCG2—thyroid gland—Graves' disease	0.00326	0.0171	CbGeAlD
Mycophenolate mofetil—ABCB1—pituitary gland—Graves' disease	0.00186	0.0098	CbGeAlD
Mycophenolate mofetil—ABCB1—adipose tissue—Graves' disease	0.00186	0.00976	CbGeAlD
Mycophenolate mofetil—ABCB1—thyroid gland—Graves' disease	0.00161	0.00845	CbGeAlD
